The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Olson, N. E.
Right arrow Articles by Clark, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olson, N. E.
Right arrow Articles by Clark, E. A.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2003, 170: 6065-6072.
Copyright © 2003 by The American Association of Immunologists

Caspase Activity Is Required for Stimulated B Lymphocytes to Enter the Cell Cycle1

N. Eric Olson2,*, Jonathan D. Graves2,{dagger}, Geraldine L. Shu2,*, Elizabeth J. Ryan* and Edward A. Clark3,*,{dagger}

Departments of * Microbiology and {dagger} Immunology, University of Washington, Seattle, WA 98195

Following activation with proliferative stimuli, including ligation of CD40, dense human tonsillar B cells (>98% cells in G0) have increased cleavage and activation of caspase-8 and -6 accompanied by decreased caspase-3 activation and apoptosis. Proliferation was blocked by either a broad specificity caspase inhibitor or inhibitors selective for caspase-6 or caspase-8. In contrast, an inhibitor selective for caspase-3 was without effect. Furthermore, induction of cyclin D and cyclin-dependent kinase 4 mRNA and protein was blocked upon inhibition of caspase-6, but not caspase-3. Thus, caspase-6-like activity is required for quiescent B cells to increase the expression of genes required for entry into G1. In support of this model, the transcriptional suppressor special AT-rich sequence-binding protein 1, a preferred caspase-6 substrate, was cleaved upon B cell stimulation. Caspase activity was not required for all signaling events, as caspase inhibitors did not affect the phosphorylation of p42/44 mitogen-activated protein kinase, the expression of the survival factor cellular inhibitor of apoptosis 2, or the production of IL-6 by stimulated G0 B cells. These findings suggest a mechanism by which caspase-6 may selectively allow entry of quiescent B cells into the cell cycle.




This article has been cited by other articles:


Home page
Cancer Res.Home page
D. Finlay, A. Howes, and K. Vuori
Critical Role for Caspase-8 in Epidermal Growth Factor Signaling
Cancer Res., June 15, 2009; 69(12): 5023 - 5029.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Janumyan, Q. Cui, L. Yan, C. G. Sansam, M. Valentin, and E. Yang
G0 Function of BCL2 and BCL-xL Requires BAX, BAK, and p27 Phosphorylation by Mirk, Revealing a Novel Role of BAX and BAK in Quiescence Regulation
J. Biol. Chem., December 5, 2008; 283(49): 34108 - 34120.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Watanabe, G. L. Shu, T. S. Zheng, R. A. Flavell, and E. A. Clark
Caspase 6 Regulates B Cell Activation and Differentiation into Plasma Cells
J. Immunol., November 15, 2008; 181(10): 6810 - 6819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-A. T. Tan, Y. Sun, J. Song, Y. Chen, T. G. Krontiris, and L. K. Durrin
SUMO Conjugation to the Matrix Attachment Region-binding Protein, Special AT-rich Sequence-binding Protein-1 (SATB1), Targets SATB1 to Promyelocytic Nuclear Bodies Where It Undergoes Caspase Cleavage
J. Biol. Chem., June 27, 2008; 283(26): 18124 - 18134.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Moarbess, H. El-Hajj, Y. Kfoury, M. E. El-Sabban, Y. Lepelletier, O. Hermine, C. Deleuze-Masquefa, P.-A. Bonnet, and A. Bazarbachi
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma
Blood, April 1, 2008; 111(7): 3770 - 3777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Truscott, J.-B. Denault, B. Goulet, L. Leduy, G. S. Salvesen, and A. Nepveu
Carboxyl-terminal Proteolytic Processing of CUX1 by a Caspase Enables Transcriptional Activation in Proliferating Cells
J. Biol. Chem., October 12, 2007; 282(41): 30216 - 30226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Zeng, S. L. Dalheimer, and T. M. Yankee
Gads-/- Mice Reveal Functionally Distinct Subsets of TCRbeta+ CD4-CD8- Double-Negative Thymocytes
J. Immunol., July 15, 2007; 179(2): 1013 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Lemmers, L. Salmena, N. Bidere, H. Su, E. Matysiak-Zablocki, K. Murakami, P. S. Ohashi, A. Jurisicova, M. Lenardo, R. Hakem, et al.
Essential Role for Caspase-8 in Toll-like Receptors and NF{kappa}B Signaling
J. Biol. Chem., March 9, 2007; 282(10): 7416 - 7423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Q. Nhan, W. C. Liles, and S. M. Schwartz
Physiological Functions of Caspases Beyond Cell Death
Am. J. Pathol., September 1, 2006; 169(3): 729 - 737.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Darnowski, F. A. Goulette, Y.-j. Guan, D. Chatterjee, Z.-F. Yang, L. P. Cousens, and Y. E. Chin
Stat3 Cleavage by Caspases: IMPACT ON FULL-LENGTH Stat3 EXPRESSION, FRAGMENT FORMATION, AND TRANSCRIPTIONAL ACTIVITY
J. Biol. Chem., June 30, 2006; 281(26): 17707 - 17717.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Werz, I. Tretiakova, A. Michel, A. Ulke-Lemee, M. Hornig, L. Franke, G. Schneider, B. Samuelsson, O. Radmark, and D. Steinhilber
Caspase-mediated degradation of human 5-lipoxygenase in B lymphocytic cells
PNAS, September 13, 2005; 102(37): 13164 - 13169.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lamkanfi, K. D'hondt, L. Vande Walle, M. van Gurp, G. Denecker, J. Demeulemeester, M. Kalai, W. Declercq, X. Saelens, and P. Vandenabeele
A Novel Caspase-2 Complex Containing TRAF2 and RIP1
J. Biol. Chem., February 25, 2005; 280(8): 6923 - 6932.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
B. Schmeck, R. Gross, P. D. N'Guessan, A. C. Hocke, S. Hammerschmidt, T. J. Mitchell, S. Rosseau, N. Suttorp, and S. Hippenstiel
Streptococcus pneumoniae-Induced Caspase 6-Dependent Apoptosis in Lung Epithelium
Infect. Immun., September 1, 2004; 72(9): 4940 - 4947.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. M. Harnett
CD40: A Growing Cytoplasmic Tale
Sci. Signal., June 15, 2004; 2004(237): pe25 - pe25.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Lamkanfi, M. Kalai, X. Saelens, W. Declercq, and P. Vandenabeele
Caspase-1 Activates Nuclear Factor of the {kappa}-Enhancer in B Cells Independently of Its Enzymatic Activity
J. Biol. Chem., June 4, 2004; 279(23): 24785 - 24793.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Sepulveda, A. V. Emelyanov, and B. K. Birshtein
NF-{kappa}B and Oct-2 Synergize to Activate the Human 3' Igh hs4 Enhancer in B Cells
J. Immunol., January 15, 2004; 172(2): 1054 - 1064.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.